My approach to pathology of the pituitary gland

被引:50
作者
Al-Brahim, N. Y. Y.
Asa, S. L.
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Toronto Med Labs, Toronto, ON, Canada
关键词
D O I
10.1136/jcp.2005.031187
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
The sellar region is the site of a large number of pathological entities arising from the pituitary and adjacent anatomical structures, including brain, blood vessels, nerves and meninges. The surgical pathology of this area requires the accurate identification of neoplastic lesions, including pituitary adenoma and carcinoma, craniopharyngioma, neurological neoplasms, germ cell tumours, haematological malignancies and metastases, as well as non-neoplastic lesions such as cysts, hyperplasias and inflammatory disorders. This review provides a practical approach to the diagnosis of pituitary specimens that are sent to the pathologist at the time of surgery. The initial examination requires routine haematoxylin and eosin staining to establish whether the lesion is a primary adenohypophysial proliferation or one of the many other pathologies that occurs in this area. The most common lesions resected surgically are pituitary adenomas. These are evaluated with several special stains and immunohistochemical markers that are now available to accurately classify these pathologies. The complex subclassification of pituitary adenomas is now recognised to reflect specific clinical features and genetic changes that predict targeted treatments for patients with pituitary disorders.
引用
收藏
页码:1245 / 1253
页数:9
相关论文
共 57 条
[1]
Invasive Pituitary Adenomas: Significance of Proliferation Parameters [J].
Amar A.P. ;
Hinton D.R. ;
Krieger M.D. ;
Weiss M.H. .
Pituitary, 1999, 2 (2) :117-122
[2]
CELL-TYPE-SPECIFIC EXPRESSION OF THE PITUITARY TRANSCRIPTION ACTIVATOR PIT-1 IN THE HUMAN PITUITARY AND PITUITARY-ADENOMAS [J].
ASA, SL ;
PUY, LA ;
LEW, AM ;
SUNDMARK, VC ;
ELSHOLTZ, HP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (05) :1275-1280
[3]
Asa SL, 2004, FRONT HORM RES, V32, P1
[4]
The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph [J].
Asa, SL ;
Bamberger, AM ;
Cao, B ;
Wong, M ;
Parker, KL ;
Ezzat, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2165-2170
[5]
The cytogenesis and pathogenesis of pituitary adenomas [J].
Asa, SL ;
Ezzat, S .
ENDOCRINE REVIEWS, 1998, 19 (06) :798-827
[6]
Asa SL., 1998, Atlas of Tumor Pathology
[7]
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly [J].
Bhayana, S ;
Booth, GL ;
Asa, SL ;
Kovacs, K ;
Ezzat, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11) :6290-6295
[8]
METASTATIC TUMORS OF THE SELLA TURCICA MASQUERADING AS PRIMARY PITUITARY-TUMORS [J].
BRANCH, CL ;
LAWS, ER .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1987, 65 (03) :469-474
[9]
The spectrum and significance of primary hypophysitis [J].
Cheung, CC ;
Ezzat, S ;
Smyth, HS ;
Asa, SL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1048-1053
[10]
BOTH PIT-1 AND THE ESTROGEN-RECEPTOR ARE REQUIRED FOR ESTROGEN RESPONSIVENESS OF THE RAT PROLACTIN GENE [J].
DAY, RN ;
KOIKE, S ;
SAKAI, M ;
MURAMATSU, M ;
MAURER, RA .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (12) :1964-1971